Results 191 to 200 of about 1,382,625 (239)

Editing around the target: epitope engineering to protect stem cell grafts. [PDF]

Blood Adv
Baek J, Casirati G, Genovese P, Gill S.
europepmc   +1 more source

The promise of immunotherapy in the treatment of sarcoma: A state-of-the-art review of practice changing research and future directions. [PDF]

Hum Vaccin Immunother
Kulkarni NJ, Kelly CM, Bartlett EK.
europepmc   +1 more source

Cryoablation combined with immunotherapy: new strategies and progress in the treatment of tumors. [PDF]

Front Oncol
Xiang Y, Yu L, Li J.
europepmc   +1 more source

Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment. [PDF]

Front Immunol
Suarez-Trujillo F, Steiner TS, Gisbert JP, Chaparro M.   +3 more
europepmc   +1 more source

Immunotherapy in Soft Tissue Sarcomas-An Ongoing Quest. [PDF]

Cells
Cobeña S, Esperança-Martins M, Syder Queiroz A, Melo-Alvim C, Costa L.   +4 more
europepmc   +1 more source

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

Angewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean, Nicolás Montesdeoca, Gilles Berger, Johannes Karges   +3 more
wiley   +1 more source

The tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications. [PDF]

Front Immunol
Zhang G, Xing C, Gong Y.
europepmc   +1 more source

Clinical trial landscape and translational prospects of natural killer cell-based immunotherapy: an analysis based on the INFORMA database. [PDF]

J Immunother Cancer
Sun H, Zhang Y, Yuan Y, Liu D, Qiao J.
europepmc   +1 more source

Glioblastoma stem cells as carriers of tumour memory: a strategy for personalised immunotherapy using tumour-infiltrating lymphocytes. [PDF]

Front Immunol
Bryukhovetskiy I, Pak O, Polevshchikov A.   +2 more
europepmc   +1 more source

T cells, the Next Big Target in Axial Spondyloarthritis?

Arthritis &Rheumatology, EarlyView.
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley   +1 more source